Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(−/−) mouse model of atherosclerosis

Cardiovascular disease (CVD) is the most prevalent cause of mortality among patients with type 1 or type 2 diabetes, due to accelerated atherosclerosis. Recent evidence suggests a strong link between atherosclerosis and insulin resistance, due to impaired insulin receptor (IR) signalling. Here, we d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Sci (Lond)
Autores principales: Thompson, Dawn, Morrice, Nicola, Grant, Louise, Le Sommer,  Samantha, Lees, Emma K., Mody, Nimesh, Wilson, Heather M., Delibegovic, Mirela
Formato: Artigo
Lenguaje:Inglês
Publicado: Portland Press Ltd. 2017
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365594/
https://ncbi.nlm.nih.gov/pubmed/28899902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20171066
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares